In our study, the top five genes in PTCL were TET2 (53%), RHOA (33%), DNMT3A (26%), IDH2 (18%), and TP53 (14%). The gene discussed is IDH2; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.